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ABSTRACT: Our aim was to examine the effects of ischemic preconditioning (IPC) on the local periosteal and systemic inflammatory
consequences of hindlimb ischemia-reperfusion (IR) in Sprague–Dawley rats with chronic estrogen deficiency (13 weeks after
ovariectomy, OVX) in the presence and absence of chronic 17beta-estradiol supplementation (E2, 20mg kg1, 5 days/week for 5 weeks);
sham-operated (non-OVX) animals served as controls. As assessed by intravital fluorescence microscopy, rolling and the firm adhesion
of polymorphonuclear neutrophil leukocytes (PMNs) gave similar results in the Shamþ IR and OVXþ IR groups in the tibial periosteal
microcirculation during the 3-h reperfusion period after a 60-min tourniquet ischemia. Postischemic increases in periosteal PMN
adhesion and PMN-derived adhesion molecule CD11b expressions, however, were significantly reduced by IPC (two cycles of 100/100) in
Sham animals, but not in OVX animals; neither plasma free radical levels (as measured by chemiluminescence), nor TNF-alpha release
was affected by IPC. E2 supplementation in OVX animals restored the IPC-related microcirculatory integrity and PMN-derived CD11b
levels, and TNF-alpha and free radical levels were reduced by IPC only with E2. An enhanced estrogen receptor beta expression could
also be demonstrated after E2 in the periosteum. Overall, the beneficial periosteal microcirculatory effects of limb IPC are lost in
chronic estrogen deficiency, but they can be restored by E2 supplementation. This suggests that the presence of endogenous estrogen is
a necessary facilitating factor of the anti-inflammatory protection provided by limb IPC in females. The IPC-independent effects of E2
on inflammatory reactions should also be taken into account in this model.  2017 Orthopaedic Research Society. Published by Wiley
Periodicals, Inc. J Orthop Res 36:97–105, 2018.
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During elective orthopedic interventions or traumas,
tourniquet application may lead to iatrogenic ischemia-
reperfusion (IR) injury of the affected extremities, which
may influence the healing of the bone and the surround-
ing soft tissues1 including the periosteum.2 The local IR
injury may lead to systemic inflammatory activation as
well,3 and the injury in distant organs (e.g., the liver and
lungs) is mediated by many factors, among others by
circulating pro-inflammatory cytokines and activated poly-
morphonuclear leukocytes (PMNs).1,4 Nevertheless, it has
been shown that short, repeated local IR periods termed
ischemic preconditioning (IPC) confer anti-inflammatory
protection both in the periosteum,5 and in remote organs
through humoral and neurogenic signals.6–9
The amelioration of IR-induced inflammatory com-
plications by limb IPC should offer a therapeutic
benefit in elderly patients when the prevalence of
skeletal injuries increases and osteoporotic bones are
more prone to accidental fractures. However, the
influence of osteoporosis on the efficacy of IPC against
IR-induced injury remains unexplored and the results
obtained concerning the estrogen status in this condi-
tion seem contradictory. Earlier it was demonstrated
that endogenous estrogen does not play a role in the
protective effect of IPC.10 Other studies have shown
that the positive cardiac effects of IPC are lost when
the endogenous estrogen levels are reduced by
ovariectomy (OVX), but cardioprotection could be
re-established by estrogen supplementation.11–13 So
far, available data on the effects of estrogen replace-
ment during IPC appear to conflict.11–14 We showed
earlier that OVX per se did not predispose female rats
to more severe inflammatory reactions, but estrogen
supplementation reduced the harmful consequences of
limb IR.15 Therefore the present study was designed to
ascertain whether IPC exerts its potentially positive
anti-inflammatory effects on limb IR injury with
chronic estrogen deficiency. In our study, we also
sought to examine whether the periosteal microcircu-
latory reactions are modulated by exogenous estrogen
supplementation. With the above in mind, we decided
to characterize the effects of IPC with or without
estrogen supplementation on local periosteal and sys-
temic inflammatory changes in a rodent model of
hindlimb IR injury with chronic estrogen deficiency.
MATERIALS AND METHODS
Animals
All studies were carried out on Sprague–Dawley rats housed
in an environmentally controlled room with a 12-h light-dark
cycle, and kept on commercial rat chow (Charles River,
Wilmington, MA) and tap water ad libitum.
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The project was approved by the National Scientific
Ethical Committee on Animal Experimentation (National
Competent Authority), with the license number: V./144/2013.
The study was performed in adherence with the EU Direc-
tive 2010/63/EU on the protection of animals used for
experimental and other scientific purposes and the National
Institute of Health guidelines for the use of experimental
animals. Animal welfare-related assessments and interven-
tions were carried out prior to and during the experiments.
Experimental Protocol
Ovariectomy
Twelve-week-old female rats (weighing 180–200 g) were
randomly allocated to ovariectomized (N¼ 48), or sham-
operated (N¼ 33) groups. The animals were anesthetized
with an intraperitoneal combination of ketamine and xyla-
zine (25mgkg1 and 75mgkg1, respectively), and a median
laparotomy was performed under sterile conditions. The
connection of the Fallopian tubes was cut between hemo-
stats, the ovaries were removed, and the stumps were then
ligated with a 3–0 non-absorbable thread (Ethibond Excel1,
Ethicon, Somerville, NJ). Thereafter, the abdomen was filled
with warm sterile physiological saline and the abdominal
wall was closed with a 4–0 absorbable suture and a 4–0 non-
absorbable suture (Vicryl1 and Prolene1, Ethicon, Somer-
ville, NJ) in two layers. Sham-operated animals underwent
identical procedures, except of course that the Fallopian
tubes and ovaries were not touched.
Chronic EstrogenTreatment
Eight weeks after OVX (i.e., at 20 weeks of age) (see Fig. 1),
a chronic estrogen therapy was initiated in some of the OVX
animals for 5 days/week with 20mgkg1 subcutaneous
17beta-estradiol16 (E2, Sigma, St. Louis, MO) and it was
continued for 5 weeks (i.e., until the end of the experimental
protocol in week 25). The remaining OVX and Sham animals
received the vehicle for E2 (100% ethanol diluted in corn oil)
in the same volume.
Experimental Series
The later in vivo experiments were performed in two major
series 13 weeks after the OVX and sham operations (in week
25) (Fig. 1). In the first series, the tibial periosteal microcir-
culatory consequences of a 60-min complete hindlimb ische-
mia followed by a 180-min reperfusion (with or without limb
IPC) were investigated with intravital videomicroscopy
(IVM). In a second series of experiments, identical protocols
in the same groups were performed in order to detect
changes in various systemic inflammatory reactions (see
later on).
Series 1: Measurement of Local Inflammatory Reactions
Using IVM
The experiments were performed under sodium pentobarbi-
tal (45mgkg1 ip) anesthesia and sustained with small
supplementary intravenous doses when necessary. The right
carotid artery and the jugular vein were cannulated for the
measurement of mean arterial pressure and the administra-
tion of drugs and fluids, respectively. The animals were
placed in a supine position on a heating pad to maintain
their body temperature between 36 and 37˚C. Here, Ringer’s
lactate was infused at a rate of 10ml kg1 h1 during the
experiments. The trachea was cannulated to facilitate respi-
ration. The right femoral artery was isolated, and the
periosteum of the medial surface of the right tibia was
exposed under a Zeiss 6 magnification operating micro-
scope, using an atraumatic surgical technique.2
In the final stage, the animals were randomly allotted to
one of the following five groups. These are shown in Figure 1,
week 25. Among vehicle-treated animals, a 60-min complete
hind limb ischemia was induced by applying a tourniquet
around the proximal femur and a miniclip on the femoral
artery, which was followed by a 180-min reperfusion period
in nine sham-operated animals (Shamþ IR group) and 11 of
the OVX animals (OVXþ IR groups). Two other vehicle-
treated groups were also subjected to two cycles of 10min of
limb IPC and 10min of reperfusion (Shamþ IPCþ IR group,
N¼ 9; OVXþ IPCþ IR group, N¼ 9).. This IPC protocol has
been shown to ameliorate local microcirculatory and systemic
inflammatory complications caused by limb IR in male rats.3
In all of the E2-treated animals, limb IR was combined with
IPC (OVXþE2þ IPCþ IR group, N¼ 6) and the experiments
were started 18–24h after the last E2 injection. In this
series, the periosteal microcirculation was observed with
IVM at baseline and every 60min during the 180-min
reperfusion period.
Microcirculatory Measurements
The right hindlimb with the exposed tibial periosteum was
positioned horizontally on an adjustable stage for examina-
tion of the microcirculation by IVM (Zeiss Axiotech Vario
100HD microscope, 100W HBO mercury lamp, Acroplan 20
water immersion objective, Carl Zeiss GmbH, Jena,
Germany). Microcirculation was visualized with fluorescein
isothiocyanate (Sigma, St. Louis, MO)-labeled erythrocytes
(0.2ml iv), while PMNs were labeled with an iv injection of
rhodamine 6G (Sigma, St. Louis, MO, 0.2%, 0.1ml iv). The
microscopic images were recorded with a charge-coupled
device video camera (Teli CS8320Bi, Toshiba Teli Corpora-
tion, Osaka, Japan) attached to an S-VHS video recorder
Figure 1. Groups and time sequence of surgical
interventions, treatments and measurements: Ovari-
ectomy (OVX) or a sham operation (Sham) was
performed at 12 weeks of age; 17beta-estradiol treat-
ment (E2) was performed for 5 weeks (5 days/week in
a dose of 20mg kg1); tourniquet-ischemia of a hin-
dlimb followed by reperfusion (IR; 600/1800) with or
without ischemic preconditioning of the hindlimb
(IPC; 2100/100) was performed at the end of the
protocol. In Series 1, the assessment of local inflam-
matory reactions in the tibial periosteum using
intravital microscopy was carried out, while in Series
2, the detection of various systemic inflammatory
parameters was performed. The number of animals
used per group in each series is indicated in brackets.
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(Panasonic AG-MD 830, Matsushita Electric Industrial Co.,
Tokyo, Japan) and a personal computer.
IVM—Video Analysis
A quantitative assessment of the microcirculatory parame-
ters was performed off-line by a frame-to-frame analysis of
the videotaped images, using image analysis software (IVM,
Pictron Ltd., Budapest, Hungary) (Fig. 2). As for the
periosteum, leukocyte–endothelial cell interactions were ana-
lyzed within five postcapillary venules (with diameters
between 11 and 20mm) per animal. IVM in the periosteum
allows the observation of the primary and secondary
PMN-endothelial interactions (rolling and adhesion, respec-
tively). Rolling is a transient and reversible process, whereas
adhesion represents a higher level of activation of leukocytes
(when endothelial contact-dependent signals trigger
the formation of the activation-dependent adhesion molecule
expression of PMNs with accompanying NADPH oxidase
activation and degranulation.17 Based on their movements
and contact with the endothelium of the postcapillary
venules, adherent leukocytes (stickers) were defined in each
vessel segment as cells that did not move or detach from the
endothelial lining within an observation period of 30 s, and
are expressed here as the number of cells per mm2 of
endothelial surface. Rolling leukocytes were defined as cells
moving at a velocity less than 40% of that of the erythrocytes
in the centerline of the microvessel, and expressed as the
number of cells/vessel circumference in millimeters.
Series 2: Detection of Systemic Inflammatory Reactions
In a second series of experiments, identical protocols for the
same groups were applied to detect changes in the pro-
inflammatory cytokine TNF-alpha concentrations in the
plasma and in whole blood free radical productions, as well
as in the expressions of a circulating PMN-derived adhesion
molecule (see the groups above, N¼ 6–9). The separation of
the two series was necessary in order to avoid any interfer-
ence between the fluorescent dyes used for IVM and acquisi-
tion techniques used with flow cytometry and luminometry.
In this series of experiments, measurements were made from
blood samples taken at baseline and at every 60min of the
reperfusion phase. And at the end of the protocol, periosteal
specimens were harvested under RNase- and DNase-free
circumstances to detect periosteal estrogen receptor (ER)
expressions, then the samples were stored at 80˚C until
assay.
Immune Labeling and Flow Cytometric Analysis of Adhesion
Molecule CD11b Expression of PMNs
The surface expression of CD11b on the peripheral blood
PMNs was determined via a flow-cytometric analysis of
whole blood in duplicate.2 100ml of whole blood was incu-
bated with 20ml of (50mgml1) fluorescein isothiocyanate-
conjugated mouse anti-rat monoclonal antibody (clone
OX-42, AbD Serotec, Kidlington, UK) for 20min. Negative
controls were obtained by omitting the monoclonal antibody.
The cells were then washed twice in Hanks buffer and
centrifuged (Heraeus Biofuge primoR, Thermo Scientific,
Waltham, MA, rotor diameter: 65mm) at 12,281 g for 5min.
The cells were again washed twice, and the erythrocytes
were lysed with a lysis puffer (Erythrolyse Red Blood Cell
Lysing Buffer (10x) Reagent, GenWay, San Diego, CA) for
8min, after which the cells were washed twice again
(2,616 g, 5min) and resuspended in 750ml of Hanks buffer.
CyFlow ML (Partec GmbH, M€unster, Germany) equipment
was used for cytometry; the granulocytes were gated on the
basis of their characteristic forward and sidescatter features.
Here, 10,000 events per sample were collected and recorded,
then the percentages of labeled (activated) granulocytes
(relative to the overall marker-bearing cells) and the mean
fluorescence intensity (average marker density) were calcu-
lated.
Determination of Plasma TNF-Alpha Levels
Blood samples (0.5ml) were taken from the carotid artery
and placed into precooled EDTA-containing polypropylene
tubes, centrifuged at 13,500 rpm for 5min at 4˚C, and then
stored at 70˚C until assay. Proinflammatory cytokine TNF-
alpha concentrations were determined in plasma samples by
means of commercially available enzyme-linked immunosor-
bent assays (Quantikine Ultrasensitive ELISA kit for rat
TNF-alpha; R&D systems, Minneapolis).
Free Radical-Producing Capacity of the Blood
10ml of blood dissolved in Hanks buffer was incubated for
20min at 37˚C in lucigenin (5mM; dissolved in Hanks buffer)
solution in the presence or absence of zymozan (190mM,
dissolved in Hanks buffer). Superoxide production was
Figure 2. Representative micrographs showing the sequence of PMN–endothelial interactions on three consecutive images (Panels
A–C) recorded by using intravital microscopy (recording rate: 20 frames/s). The segment of the examined tibial postcapillary vein is
surrounded by lines in Panel A. Movement of rhodamine 6G-labeled PMN (marked by a–c) is demonstrated frame-by-frame referring to
a dashed line. Stationary (adhesive) leukocytes are marked by ellipses. The bar in Panel C denotes 50mm scale and this applies to all
photomicrographs.
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estimated via the rate of zymozan-induced increase in
chemiluminescence (measured with an FB12 Single Tube
Luminometer (Berthold Detection Systems GmbH, Bad Wild-
bad, Germany) and normalized for leukocyte counts in the
peripheral blood.
Determination of Plasma E2 Levels
Endogenous E2 levels were determined using the Elecsys
Estradiol III kit (Roche Diagnostics GmbH, Mannheim,
Germany) and the Roche Cobas e 601 immunology analyzer
(Roche Diagnostics GmbH, Mannheim, Germany).
Determination of Periosteal Estrogen Receptor-Alpha (ER-Alpha)
and Beta (ER-Beta) mRNA Expressions
Tissue Collection
Anteromedial tibial periosteal samples were harvested via
sterile surgical exposure of the contralateral (non-ischemic)
limbs under an operating microscope. The samples were
washed in 0.3ml of sterile DNase, RNase and protease-free
water (Sigma, St. Louis, MO) and placed in RNA stabiliza-
tion solution (0.2ml/each sample; RNAlater, Ambion1,
Thermo Fisher Scientific, Waltham, MA). After overnight
storage at 4˚C, the RNA stabilization solution was removed,
and tissue samples were stored at 80˚C until RNA purifica-
tion. Here, uterus samples were used as internal controls.
RNA Purification
The total RNA taken from the tibial periosteum and the
uterus of each animal was purified with the NucleoSpin1
RNA XS kit (Macherey-Nagel GmbH & Co. KG, D€uren,
Germany) according to the protocol provided by the manufac-
turer.
Real Time PCR for ER-Alpha and ER-Beta
100ng of RNA template in a 10ml reaction mix were
measured, using a quantitative reverse transcriptase-medi-
ated PCR kit (Verso 1-step RT-qPCR Mix, ROX kit; Thermo
Fisher Scientific, Waltham, MA). The amplification condi-
tions were 50˚C for 15min, 95˚C for 15min, 40 cycles of
95˚C for 15 s, and 58˚C for 15 s. RNA levels were calculated
using the DDCT method and were normalized to 18S mRNA.
The Universal Probe Library (UPL) system (Roche, Basel,
Switzerland) was used to design primers and probes for the
experiments (see Table 1).
Statistical Analysis
The required number of animals (i.e., sample size) was
assessed by using the PS Power and Sample Size Calcula-
tions software package (version 3.1.2) prior to the experi-
ments. Data analysis was performed with the SigmaStat
statistical software package (Jandel Corporation, San Rafael,
CA). The normality of data sets was checked, and in case of
normal distribution, changes in variables within and be-
tween groups were analyzed by the two-way repeated
measures ANOVA test, followed by the Holm–Sidak test.
Data are expressed as means standard error of the mean
(SEM). Due to the non-Gaussian distribution, PCR data were
analyzed by the Kruskal–Wallis test, followed by the Dun-
nett test; the box plot figure shows the mean, the median,
and the 25th and 75th percentile values. p values <0.05 were
considered statistically significant at all parameters.
RESULTS
Effects of Local IPC on the Postischemic Tibial Periosteal
Microcirculatory Inflammatory Reactions With Estrogen
Depletion
When compared with the baseline values, the values of
primary PMN–endothelial interactions (termed rolling)
in the postcapillary venules of the tibial periosteum
increased to a similar extent in the Shamþ IR and
OVXþ IR animals at all examined time-points of reper-
fusion after limb IR (see Fig. 3). When limb IR was
combined with local IPC, moderately reduced rolling
values were observed in non-ovariectomized rats (Sham
þ IPCþ IR group) at later stages of reperfusion (120
and 180min), but no reduction was seen in OVX rats
(OVXþ IPCþ IR group). At 60 and 120min of reperfu-
sion, the lowest rolling values were detected in animals
treated with chronic E2 (OVXþE2þ IPCþ IR group),
but these differences were not statistically significant.
Leukocyte adherence (sticking) revealed a similar
pattern to that seen with PMN rolling; no ameliorating
effect of IPC was seen in OVX animals (in the
OVXþ IPCþ IR group), but some alleviating effect was
observed after E2 treatment (in OVXþE2 þ IPCþ IR
group) (see Fig. 4).
Systemic Inflammatory Reactions
An increased expression of the adhesion molecule CD11b
on the PMN surface was observed after 120 and 180min
of reperfusion. After, no major differences could be seen
between the values for the Shamþ IR and OVXþ IR
groups, but a slight decrease was observed after IPC in
sham-operated animals (Shamþ IPCþ IR) (see Fig. 5).
This amelioration, however, was not seen after OVX (in
the OVXþ IPCþ IR group). It seems that chronic E2
treatment effectively prevented the IR-induced increase
in CD11b expression (OVXþ IPCþ IRþE2).
The free radical-derived chemiluminescence of the
whole blood (as determined by the superoxide radical-
dependent chemiluminescence measurements) gave
the earliest increase (after 60min of reperfusion) after
IPC both in the sham-operated and OVX animals
(Shamþ IPCþ IR and OVXþ IPCþ IR), but it rose
only slightly in the E2-treated OVXþ IPCþ IR ani-
mals (OVXþE2þ IPCþ IR) at this time point (see
Fig. 6). Free radical production did not reveal any
Table 1. Primers and Probes for Quantitative RT-PCR Used in This Study
Target Forward Primer Reverse Primer Probe
ER-alpha TTCTTTAAGAGAAGCATTCAAGGAC TCTTATCGATGGTGCATTGG # 130; 04693663001
ER-beta GGCTGGGCCAAGAAAATC TCTAAGAGCCGGACTTGGTC # 111; 04693442001
18S CTCAACACGGGAAACCTCAC CGCTCCACCAACTAAGAACG # 77; 04689003001
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more differences between the different experimental
groups at later time points.
From the experiments, we found that IR brought
about a significant increase in TNF-alpha levels in the
plasma in all of the groups (see Fig. 7). Due to the high
data dispersion, no statistically significant differences
were seen between the groups at any time point, but the
lowest increase was observed in the E2-treated animals.
The protocol was not synchronized with the estrous
cycles of the animals and vaginal smear tests were not
performed. The serum E2 concentrations ranged from
9.57 to 15.87pg/ml in the Sham-operated animals, while
these levels were significantly lower in the OVX animals
(p< 0.001), not even attaining the detection limit of the
assay (>5pg/ml). However, plasma E2 was restored by
chronic E2 supplementation in the OVX animals and the
values were slightly higher than those in the Sham
group (20.06 median value pg/ml, p< 0.05).
Periosteal Estrogen Receptor Expression
In the periosteum, a similar level of ER-beta transcrip-
tion was observed in the sham-operated and in the
OVX animals; and the highest transcription level was
noted after chronic E2 supplementation (see Fig. 8).
Periosteal ER-alpha mRNA levels, however, remained
below the detector threshold. We excluded any meth-
odological issues related to the detection of ER-alpha
by simultaneously examining uterus samples taken
from the same animals for an mRNA analysis of both
receptors. Similar to Mohamed and Abdel-Rahman,18
Figure 3. Changes in primary leukocyte–endothelial cell inter-
actions (rolling) in the postcapillary venules of the tibial perios-
teum at baseline, 60, 120, and 180min after a 60-min limb
ischemia. Sham: Sham operation; OVX: ovariectomy; IR: tourni-
quet-ischemia of a hindlimb followed by reperfusion (600/1800);
IPC: hindlimb ischemic preconditioning (2 100/100); E2: 17beta-
estradiol treatment. Two-way RM ANOVA was followed by the
Holm-Sidak test. Here, data values are given as meansSEM,
and p<0.05 versus baseline.
Figure 4. Changes in secondary leukocyte–endothelial cell
interactions (adherence) in the postcapillary venules of the tibial
periosteum at baseline, and 60, 120, and 180min after a 60-min
limb ischemia. Sham: Sham operation; OVX: ovariectomy; IR:
tourniquet-ischemia of a hindlimb followed by reperfusion
(600/1800); IPC: hindlimb ischemic preconditioning (2 100/100);
E2: 17beta-estradiol treatment. Two-way RM ANOVA was
followed by the Holm–Sidak test. Here, data values are given as
meansSEM, and p<0.05 versus baseline and #p<0.05 versus
Shamþ IR.
Figure 5. Changes in expression of the CD11b adhesion
molecule on the surface of PMNs at baseline and in response to
60min of limb ischemia followed by 120 and 180min of reperfu-
sion. Sham: Sham operation; OVX: ovariectomy; IR: tourniquet-
ischemia of a hindlimb followed by reperfusion (600/1800); IPC:
hindlimb ischemic preconditioning (2100/100); E2: 17beta-estra-
diol treatment. Two-way RM ANOVA was followed by the
Holm–Sidak test. Here, data values are given as meansSEM,
and p<0.05 versus baseline and #p< 0.05 versus Shamþ IR.
Figure 6. Whole blood superoxide production at baseline and
in response to 60min of limb ischemia followed by 60, 120, and
180min of reperfusion. Sham: Sham operation; OVX: ovariec-
tomy; IR: tourniquet-ischemia of a hindlimb followed by
reperfusion (600/1800); IPC: hindlimb ischemic preconditioning
(2100/100); E2: 17beta-estradiol treatment. Two-way RM
ANOVA was followed by the Holm–Sidak test. Here, data values
are given as meansSEM, and p<0.05 versus baseline,
#p<0.05 versus Shamþ IR.
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we found higher mRNA levels (for both ER-alpha and
beta) in the uterus in OVX group than in the Sham
group (data not shown).
DISCUSSION
Previously we examined the periosteal microcircula-
tory consequences of tourniquet-induced ischemia in a
clinically relevant, long-term follow-up study with
osteoporotic rats.15 We showed that OVX did not
enhance IR-induced periosteal microcirculation dys-
function, but chronic estrogen supplementation ame-
liorated the local inflammatory complications. In the
present protocol we employed a shorter term of OVX,
which does not cause osteopenia, but it is sufficient to
evoke a chronic estrogen deficit in rats.19 It appears
that IPC mostly influences the second stage of IR-
induced periosteal PMN-endothelial interactions
(sticking) both here in females and in males,3 which
might be explained by the effect of IPC on adhesion
molecule expression responsible for leukocyte adhesion
to the postischemic endothelium.3 This protection,
however, disappeared in the OVX animals in this
study, as both PMN rolling and adhesion increased.
Hence, it appears that the IPC-induced periosteal
protection against postischemic inflammatory compli-
cations is lost after estrogen depletion and this obser-
vation has potential clinical implications. In a similar
way, CD11b expression (a marker of activation of
circulating PMNs20 was lower in IPC animals only if
OVX was not performed. It is therefore reasonable to
suppose that endogenous estrogen in females plays a
facilitating role in the anti-inflammatory mechanisms
provided by IPC in the periosteum. This hypothesis is
supported by the observation that E2 supplementation
reverses the protection that was lost in OVXþ IPCþ
IR animals. Similarly to our present results, the
positive effects of IPC were shown to vanish in
postischemic hearts harvested from OVX rats, and
reversed by E2.11 Prior to this, the microcirculatory
benefits of E2 supplementation were examined after
IR, without IPC. The postischemic periosteal microcir-
culatory complications of tourniquet ischemia could be
reversed by E2 supplementation15 and E2 has also
been shown to have beneficial microcirculatory effects
in numerous other models of IR.21–22 Since the allevi-
ating effects of E2 are present with or without IPC, it
is difficult to differentiate between the beneficial
effects of E2 treatment per se and its effect on IPC.
Hence, one may suppose that the beneficial effects of
E2 seen in this model might be independent of its
effects on IPC.
In our study, the microcirculatory manifestations of
reduced efficacy of IPC after OVX were demonstrated for
the first time, but similar reactions were observed with
other manifestations of postischemic tissue injury in
other organs by others (i.e., cardiac dysfunction).11–14
The consequences of E2 supplementation in these
scenarios, however, are not at all clear. As such, the
OVX-related loss of IPC-induced protection in cardiac
functions could be restored by E2 in certain studies with
rats.11–12 The results are somewhat controversial, as the
protective effects of IPC were present in OVX rabbits.10
Also, E2 did not exert any alleviating effects in other
studies where IPC was combined with OVX.13–14
Furthermore, long- and short-term estrogen administra-
tion produced different effects,12,23 and inter-species and
inter-organ differences and dissimilarities cannot be
ruled out either.10,12–13,24 The reason for the differences
Figure 7. TNF-alpha levels in plasma samples at baseline and
in response to 60min of limb ischemia followed by 120, and
180min of reperfusion. Sham: Sham operation; OVX: ovariectomy;
IR: tourniquet-ischemia of a hindlimb followed by reperfusion
(600/1800); IPC: hindlimb ischemic preconditioning (2 100/100); E2:
17beta-estradiol treatment. Two-way RM ANOVA was followed by
the Holm–Sidak test. Here, data values are given as means
SEM, and p< 0.05 versus baseline.
Figure 8. ER-beta mRNA expression levels in the tibial
periosteum taken from sham-operated (Sham), ovariectomized
(OVX) and OVX animals that were treated with 17beta-estradiol
(OVXþE2). Kruskal-Wallis test was followed by the Dunnett
test. Here, data values are given as mean, median, 25th and
75th percentiles, and #p<0.05 versus Sham.
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between endogenous and exogenous estrogen effects in
different experimental models is not well understood.
Some of the above differences might be due to the
number and function of estrogen receptors within the
affected tissue and also due to the effect of OVX and
E2 on these receptor expressions. E2 is known to act
as a transcription factor, as the binding of E2 to its
ER-alpha or ER-beta receptors within the nucleus
causes well-known genomic effects by inducing expres-
sion changes of different genes (e.g., nitric oxide
synthase).25 In addition, the action of binding E2 to its
(plasma and mitochondrial) membrane-associated
receptors also mediates non-genomic events26–27 in-
cluding the prevention of injury/stress-induced
apoptosis26 and cytochrome c release from myocardial
mitochondria.28 In our investigations, the ER-beta
expression in the periosteum did not vary in response
to OVX, but displayed an elevation in response to
chronic E2 treatment (whereas the ER-alpha expres-
sion remained below the detector threshold). The up-
regulation of the ER-beta receptor expression by E2 in
the mitochondria and inhibition of apoptotic processes
seems to be linked to the protective effect of E2 in
trauma-hemorrhage.29 Moreover, cardioprotective
effects of E2 were attributable to the ER-beta receptor-
related changes in the transcription on metabolic
genes in another study.30 In all likelihood, ER-beta is
involved in regulating the estrogen-related increase in
nitric oxide synthase activation25 and others demon-
strated the impact of ER-alpha as well.31 PMN-related
inflammatory processes were enhanced in OVX rats
after trauma-induced hemorrhagic shock, which was
prevented by the acute administration of E2 and an
ER-beta agonist.24 In vivo gene delivery of ER-beta to
the endothelium greatly reduced the IR-induced for-
mation of reactive oxygen species, increased nitric
oxide formation and restored mitochondrial function in
the adjacent cardiomyocytes.32 In our study, some of
the inflammatory processes (the CD11b expression of
PMNs and free radical content in the blood) could be
ameliorated by chronic E2; and the possible role of
the up-regulation of ER-beta in these reactions cannot
be ruled out. It should be noted, however, that estro-
gens also have a direct free radical scavenging effect
via their phenolic A-ring,33 a glutathione increasing
effect,34 and a direct modulatory action on NADPH
activity.35 Antioxidant effects of E2 may also be
related to its influence on NFkB signaling36 and
the up-regulating of Nrf2.37 As for the systemic effects,
the involvement of ER-alpha-related actions of E2 also
plays a role (in heart IR without IPC38), but discussion
of these reactions as well as those evoked by selective
estrogen modulators lies outside the scope of the
present study. As was suggested by Murphy and
Steenbergen, the shorter-term effects of E2 may be
caused by ER-alpha, whereas longer-term effects may
be mediated mainly through ER-beta.39 Moreover,
ER-independent effects of E2 in this study should not
be ruled out either. It should be mentioned that the
periosteal expression of ERs has not yet been exam-
ined in humans, but in the cortical and trabecular
bone tissue, both ER proteins can be detected (via
immunohistochemistry) with a different density dur-
ing bone development.40 It appears that only the
ER-beta mRNA expression was examined in the tibial
periosteum in the rat41 and here we were unable to
detect any ER-alpha mRNA expression of in the
periosteum. This might mean that ER-alpha mRNA
expression is not detectable in the periosteum. How-
ever, the translation of our present findings (the
absence of periosteal ER-alpha mRNA expression) to
the human situation requires further in-depth investi-
gation.
Systemic inflammatory parameters also displayed
characteristic changes. That is, the IR-induced
increase in CD11b expression of circulating PMNs (a
marker of their activation) was reduced by IPC only in
sham-operated animals, but not in those with OVX.
This reaction was also reversed by E2. The PMN-
derived CD11b expression was likewise reduced by E2
in vitro42 and in trauma-hemorrhagic shock43 as well
as in levels of some of other adhesion molecules such
as the E-selectin.44 We have not come across any
studies that investigated the effect of IPC in OVX
animals from the viewpoint of adhesion molecule
expressions. In the present study, whole blood free
radical content was significantly increased in all
groups. In the Shamþ IR and OVXþ IR groups, local
(periosteal) and systemic inflammatory reactions had a
slightly different timeframe, since IVM data revealed
increased PMN rolling and adhesion after 60min of
reperfusion (indicating an early activation of the
affected endothelium and a simultaneous availability
of primed leukocytes), but the superoxide levels dis-
played later changes (occurring after 120min). The
background of this phenomenon is not yet under-
stood, but since increased CD11b expression in
peripheral leukocytes also occurred at later stages of
reperfusion (after 120min), the contribution of other
elements (e.g., activated macrophages) to the in-
creased superoxide production may be assumed.
Interestingly, IPC failed to induce any amelioration
in whole blood free radical production, and further-
more, it induced an earlier increase in this parame-
ter in both sham-operated and OVX groups. It should
also be mentioned that this increase was not present
in the E2-treated group. Actually, free radicals are
known to play a role in the pathomechanism of IPC
because their accumulation could be detected in vivo
and superoxide scavengers reversed the tissue pro-
tective effects of IPC.45–46 ER-beta has been shown
elsewhere to be involved in reducing neutrophil
activation24 and the free radical reducing effect of E2
was also highlighted.47 Interestingly, levels of one of
the central regulators of inflammation TNF-alpha
were not influenced by IPC. Quite surprisingly,
the phenomenon observed in humans48 indicating
increased serum TNF-alpha levels after OVX could
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not be confirmed in the present study (i.e., the
baseline TNF-alpha values were not dissimilar after
OVX), and even slightly lower values were found in
all of the OVX animals (after 120min of reperfusion).
These differences might be the result of interspecies
differences or changes in the immunological
responses seen after OVX (which are outside the
scope of the present study). TNF-alpha release has
been shown to be reduced by E2 in numerous studies
(with or without OVX),23,49 even in male patients.50
In this respect, the changes induced by reperfusion
or IPCþ IR have yet to be compared in OVX studies
elsewhere. Here, the lowest postischemic values were
found after applying E2 (although not attaining any
statistical significance due to the relatively high data
dispersion). This parameter together with reduced
CD11b expression and the slower postischemic in-
crease in superoxide production represent manifesta-
tions of the alleviated systemic inflammatory
reactions after E2 supplementation.
CONCLUSIONS
In our study, we found that the beneficial periosteal
microcirculatory effects of local limb IPC vanished
after OVX in rats. These observations suggest that in
postmenopausal females during orthopedic-trauma
interventions, the efficacy of limb IPC in preventing
the inflammatory complications of tourniquet ischemia
might be limited. This conclusion is strengthened by
our findings which show that E2 supplementation
reversed these changes by alleviating the local and
systemic inflammatory reactions. Based on our previ-
ous and present findings in rats, some of the alleviat-
ing effects of E2 seen here might be independent of its
effects on IPC and may be linked to those seen with
periosteal ER-beta expression. The clinical significance
of this finding, however, remains to be elucidated.
AUTHORS’ CONTRIBUTIONS
The experiments, the analysis of microcirculation
data, the interpretation of data and drafting were
carried out by LP, AJ, DG, and JK. The PCR analysis
was supervised by GT and the FACS analysis was
supervised by IO. The research design, drafting, and
critical revision of the manuscript were performed by
MB, JP, and AS. All the authors have read and
approved the final submitted manuscript.
ACKNOWLEDGMENTS
This study was supported by Hungarian Scientific Research
Fund grants OTKA 104656 and OTKA 109388, European
Regional Development Funds grants: GINOP-2.3.2-15-2016-
00015 and EFOP-3.6.2-16-2017-00006 and National
Research, Development and Innovation Office grant NKFIH
K116689 (Hungary). The authors are grateful to Csilla
Mester and Nikolett Beretka for their assistance.
REFERENCES
1. Seekamp A, Warren JS, Remick DG, et al. 1993. Require-
ments for tumor necrosis factor-alpha and interleukin-1 in
limb ischemia/reperfusion injury and associated lung injury.
Am J Pathol 143:453–463.
2. Varga R, T€or€ok L, Szabo A, et al. 2008. Effects of colloid
solutions on ischemia-reperfusion-induced periosteal micro-
circulatory and inflammatory reactions: comparison of dex-
tran, gelatin, and hydroxyethyl starch. Crit Care Med
36:2828–2837.
3. Szabo A, Varga R, Keresztes M, et al. 2009. Ischemic limb
preconditioning downregulates systemic inflammatory acti-
vation. J Orthop Res 27:897–902.
4. Vega VL, Maldonado M, Mardones L, et al. 1999. Role of
K€upffer cells and PMN leukocytes in hepatic and systemic
oxidative stress in rats subjected to tourniquet shock. Shock
11:403–410.
5. Hartmann P, Varga R, Zobolyak Z, et al. 2011. Anti-
inflammatory effects of limb ischaemic preconditioning are
mediated by sensory nerve activation in rats. Naunyn
Schmiedebergs Arch Pharmacol 383:179–189.
6. Garab D, Fet N, Szabo A, et al. 2014. Remote ischemic
preconditioning differentially affects NADPH oxidase iso-
forms during hepatic ischemia-reperfusion. Life Sci
105:14–21.
7. Hu S, Dong H, Zhang H, et al. 2012. Noninvasive limb
remote ischemic preconditioning contributes neuroprotective
effects via activation of adenosine A1 receptor and redox
status after transient focal cerebral ischemia in rats. Brain
Res 1459:81–90.
8. Lai IR, Chang KJ, Chen CF, et al. 2006. Transient limb
ischemia induces remote preconditioning in liver among
rats: the protective role of heme oxygenase-1. Transplanta-
tion 81:1311–1317.
9. Wei D, Ren C, Chen X, et al. 2012. The chronic protective
effects of limb remote preconditioning and the underlying
mechanisms involved in inflammatory factors in rat stroke.
PLoS ONE 7:e30892.
10. Sbarouni E, Iliodromitis EK, Zoga A, et al. 2006. The effect
of the phytoestrogen genistein on myocardial protection,
preconditioning and oxidative stress. Cardiovasc Drugs Ther
20:253–258.
11. Shinmura K, Nagai M, Tamaki K, et al. 2008. Loss of
ischaemic preconditioning in ovariectomized rat hearts:
possible involvement of impaired protein kinase C epsilon
phosphorylation. Cardiovasc Res 79:387–394.
12. Kolodgie FD, Farb A, Litovsky SH, et al. 1997. Myocardial
protection of contractile function after global ischemia by
physiologic estrogen replacement in the ovariectomized rat.
J Mol Cell Cardiol 29:2403–2414.
13. Song X, Li G, Vaage J, et al. 2003. Effects of sex,
gonadectomy, and oestrogen substitution on ischaemic pre-
conditioning and ischaemia-reperfusion injury in mice. Acta
Physiol Scand 177:459–466.
14. Peng WJ, Yu J, Deng S, et al. 2004. Effect of estrogen
replacement treatment on ischemic preconditioning in iso-
lated rat hearts. Can J Physiol Pharmacol 82:339–344.
15. Szabo A, Hartmann P, Varga R, et al. 2011. Periosteal
microcirculatory action of chronic estrogen supplementation
in osteoporotic rats challenged with tourniquet ischemia.
Life Sci 88:156–162.
16. Sims NA, Morris HA, Moore RJ, et al. 1996. Estradiol
treatment transiently increases trabecular bone volume in
ovariectomized rats. Bone 19:455–461.
17. Kolaczkowska E, Kubes P. 2013. Neutrophil recruitment
and function in health and inflammation. Nat Rev Immunol
13:159–175.
18. Mohamed MK, Abdel-Rahman AA. 2000. Effect of long-term
ovariectomy and estrogen replacement on the expression of
estrogen receptor gene in female rats. Eur J Endocrinol
142:307–314.
104 POCS ET AL.
JOURNAL OF ORTHOPAEDIC RESEARCH1 JANUARY 2018
19. Iwaniec UT, Samnegård E, Cullen DM, et al. 2001. Mainte-
nance of cancellous bone in ovariectomized, human parathy-
roid hormone [hPTH(1-84)]-treated rats by estrogen,
risedronate, or reduced hPTH. Bone 29:352–360.
20. Jones DH, Anderson DC, Burr BL, et al. 1988. Quantitation
of intracellular Mac-1 (CD11b/CD18) pools in human neutro-
phils. J Leukoc Biol 44:535–544.
21. Booth EA, Marchesi M, Kilbourne EJ, et al. 2003. 17Beta-
estradiol as a receptor-mediated cardioprotective agent.
J Pharmacol Exp Ther 307:395–401.
22. Burkhardt M, Slotta JE, Garcia P, et al. 2008. The effect of
estrogen on hepatic microcirculation after ischemia/reperfu-
sion. Int J Colorectal Dis 23:113–119.
23. Babiker FA, Hoteit LJ, Joseph S, et al. 2012. The role of
17-beta estradiol in ischemic preconditioning protection of
the heart. Exp Clin Cardiol 17:95–100.
24. Doucet DR, Bonitz RP, Feinman R, et al. 2010. Estrogenic
hormone modulation abrogates changes in red blood cell
deformability and neutrophil activation in trauma hemor-
rhagic shock. J Trauma 68:35–41.
25. Nuedling S, Kahlert S, Loebbert K, et al. 1999. 17 Beta-
estradiol stimulates expression of endothelial and inducible
NO synthase in rat myocardium in-vitro and in-vivo.
Cardiovasc Res 43:666–674.
26. Stefano GB, Prevot V, Beauvillain JC, et al. 2000. Cell-surface
estrogen receptors mediate calcium-dependent nitric oxide
release in human endothelia. Circulation 101:1594–1597.
27. Simoncini T, Hafezi-Moghadam A, Brazil DP, et al. 2000.
Interaction of oestrogen receptor with the regulatory subunit
of phosphatidylinositol-3-OH kinase. Nature 407:538–541.
28. Hsieh YC, Yu HP, Suzuki T, et al. 2006. Upregulation of
mitochondrial respiratory complex IV by estrogen receptor-
beta is critical for inhibiting mitochondrial apoptotic
signaling and restoring cardiac functions following trauma-
hemorrhage. J Mol Cell Cardiol 41:511–521.
29. Hsieh YC, Choudhry MA, Yu HP, et al. 2006. Inhibition of
cardiac PGC-1alpha expression abolishes ERbeta agonist-
mediated cardioprotection following trauma-hemorrhage.
FASEB J 20:1109–1117.
30. Gabel SA, Walker VR, London RE, et al. 2005. Estrogen
receptor beta mediates gender differences in ischemia/reper-
fusion injury. J Mol Cell Cardiol 38:289–297.
31. Haynes MP, Sinha D, Russell KS, et al. 2000. Membrane
estrogen receptor engagement activates endothelial nitric
oxide synthase via the PI3-kinase-Akt pathway in human
endothelial cells. Circ Res 87:677–682.
32. Zhan Y, Liu Z, Li M, et al. 2016. ERb expression in the
endothelium ameliorates ischemia/reperfusion-mediated oxi-
dative burst and vascular injury. Free Radic Biol Med 96:
223–233.
33. Prokai L, Rivera-Portalatin NM, Prokai-Tatrai K. 2013.
Quantitative structure-activity relationships predicting the
antioxidant potency of 17b-estradiol-related polycyclic phe-
nols to inhibit lipid peroxidation. Int J Mol Sci 14:1443–1454.
34. Urata Y, Ihara Y, Murata H, et al. 2006. 17Beta-estradiol
protects against oxidative stress-induced cell death through
the glutathione/glutaredoxin-dependent redox regulation of
Akt in myocardiac H9c2 cells. J Biol Chem 281:13092–13102.
35. Dantas AP, Tostes RC, Fortes ZB, et al. 2002. In vivo
evidence for antioxidant potential of estrogen in microvessels
of female spontaneously hypertensive rats. Hypertension 39:
405–411.
36. Xing D, Oparil S, Yu H, et al. 2012. Estrogen modulates
NFkB signaling by enhancing IkBa levels and blocking p65
binding at the promoters of inflammatory genes via estrogen
receptor-b. PLoS ONE 7:e36890.
37. Yu J, Zhao Y, Li B, et al. 2012. 17b-estradiol regulates the
expression of antioxidant enzymes in myocardial cells by
increasing Nrf2 translocation. J Biochem Mol Toxicol
26:264–269.
38. Favre J, Gao J, Henry JP, et al. 2010. Endothelial estrogen
receptor {alpha} plays an essential role in the coronary and
myocardial protective effects of estradiol in ischemia/reper-
fusion. Arterioscler Thromb Vasc Biol 30:2562–2567.
39. Murphy E, Steenbergen C. 2007. Gender-based differences
in mechanisms of protection in myocardial ischemia-
reperfusion injury. Cardiovasc Res 75:478–486.
40. Bord S, Horner A, Beavan S, et al. 2001. Estrogen receptors
alpha and beta are differentially expressed in developing
human bone. J Clin Endocrinol Metab 86:2309–2314.
41. Petersen DN, Tkalcevic GT, Koza-Taylor PH, et al. 1998.
Identification of estrogen receptor beta2, a functional variant
of estrogen receptor beta expressed in normal rat tissues.
Endocrinology 139:1082–1092.
42. Nadkarni S, Cooper D, Brancaleone V, et al. 2011. Activa-
tion of the annexin A1 pathway underlies the protective
effects exerted by estrogen in polymorphonuclear leukocytes.
Arterioscler Thromb Vasc Biol 31:2749–2759.
43. Deitch EA, Ananthakrishnan P, Cohen DB, et al. 2006.
Neutrophil activation is modulated by sex hormones after
trauma-hemorrhagic shock and burn injuries. Am J Physiol
Heart Circ Physiol 291:H1456–H1465.
44. Prestwood KM, Unson C, Kulldorff M, et al. 2004. The effect
of different doses of micronized 17beta-estradiol on
C-reactive protein, interleukin-6, and lipids in older women.
J Gerontol A Biol Sci Med Sci 59:827–832.
45. Kevin LG, Camara AK, Riess ML, et al. 2003. Ischemic
preconditioning alters real-time measure of O2 radicals in
intact hearts with ischemia and reperfusion. Am J Physiol
Heart Circ Physiol 284:H566–H574.
46. Baines CP, Goto M, Downey JM. 1997. Oxygen radicals
released during ischemic preconditioning contribute to car-
dioprotection in the rabbit myocardium. J Mol Cell Cardiol
29:207–216.
47. Sovershaev MA, Egorina EM, Andreasen TV, et al. 2006.
Preconditioning by 17beta-estradiol in isolated rat heart
depends on PI3-K/PKB pathway, PKC, and ROS. Am J
Physiol Heart Circ Physiol 291:H1554–H1562.
48. Pfeilschifter J, K€oditz R, Pfohl M, et al. 2002. Changes in
proinflammatory cytokine activity after menopause. Endocr
Rev 23:90–119.
49. Ma XL, Gao F, Chen J, et al. 2001. Endothelial protective
and antishock effects of a selective estrogen receptor mod-
ulator in rats. Am J Physiol Heart Circ Physiol 280:
H876–H884.
50. Wei M, Kuukasj€arvi P, Kaukinen S, et al. 2001. Anti-
inflammatory effects of 17beta-estradiol pretreatment in
men after coronary artery surgery. J Cardiothorac Vasc
Anesth 15:455–459.
SUPPORTING INFORMATION
Additional supporting information may be found in the
online version of this article.
ESTROGEN AND LIMB ISCHEMIC PRECONDITIONING 105
JOURNAL OF ORTHOPAEDIC RESEARCH1 JANUARY 2018
